Literature DB >> 2923605

Coronary collateral reserve during exercise induced ischemia in swine.

F C White1, D M Roth, C M Bloor.   

Abstract

We determined coronary collateral vasodilator reserve during exercise-induced ischemia in 17 mini-swine. We induced coronary collateral development in the left circumflex bed by placing an ameroid occluder on that artery. Four weeks later we studied the animals at rest and during exercise (EX) eliciting heart rates (HR) of 240 and 265 beats/min. We measured myocardial blood flow with microspheres and myocardial function by wall thickness sonomicrometry gauges. At matched exercise HRs we treated the animals with nifedipine (10 micrograms/kg IV) (EXN 10), nifedipine (100 micrograms/kg IV), (EXN 100), and adenosine infusion (1.2 mg/min/kg) EXAD. EXN 10 did not significantly alter hemodynamics compared to EX but EXN 100 and EXAD both decreased blood pressure significantly (p less than 0.05). Ischemic endocardial/nonischemic endocardial flow ratios and collateral resistance served as indices of vasodilator reserve. In the ischemic zone exercise reduced vasodilator reserve to 24 +/- 3% in the endocardium and 64 +/- 7% in the epicardium. Neither EXN 10 nor EXAD improved exercise-induced ischemia measured either as flow or function. However EXN 100 improved function during exercise-induced ischemia without improving coronary collateral flow. We conclude there is no additional coronary flow reserve during exercise-induced ischemia in the collateral dependent bed of the pig a few days after occlusion that can be recruited. Large doses of nifedipine improve function by direct action on the myocardium or by reducing afterload. The lack of development and deep myocardial distribution of the coronary collateral vessels in the pig may be an important factor of why these nifedipine responses differ from those reported in species which have primarily large epicardial coronary collaterals.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2923605     DOI: 10.1007/BF01907002

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  27 in total

1.  Attenuation of exercise-induced myocardial ischemia in dogs with recruitment of coronary vasodilator reserve by nifedipine.

Authors:  G Heusch; B D Guth; R Seitelberger; J Ross
Journal:  Circulation       Date:  1987-02       Impact factor: 29.690

2.  Reduced regional myocardial perfusion in the presence of pharmacologic vasodilator reserve.

Authors:  J M Canty; F J Klocke
Journal:  Circulation       Date:  1985-02       Impact factor: 29.690

3.  Development of coronary collateral circulation in left circumflex Ameroid-occluded swine myocardium.

Authors:  D M Roth; Y Maruoka; J Rogers; F C White; J C Longhurst; C M Bloor
Journal:  Am J Physiol       Date:  1987-11

4.  Effects of nifedipine and diltiazem on coronary reactive hyperaemia.

Authors:  D J Dymek; R J Bache
Journal:  Cardiovasc Res       Date:  1984-04       Impact factor: 10.787

5.  Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.

Authors:  M G Zyvoloski; H L Brooks; G J Gross; D C Warltier
Journal:  J Pharmacol Exp Ther       Date:  1982-08       Impact factor: 4.030

6.  Effects of nifedipine on myocardial perfusion and ischemic injury in dogs.

Authors:  P D Henry; R Shuchleib; L J Borda; R Roberts; J R Williamson; B E Sobel
Journal:  Circ Res       Date:  1978-09       Impact factor: 17.367

7.  Persistence of coronary vasodilator reserve despite functionally significant flow reduction.

Authors:  T Aversano; L C Becker
Journal:  Am J Physiol       Date:  1985-03

8.  Incomplete coronary vasodilation during myocardial ischemia in swine.

Authors:  G A Pantely; J D Bristow; L J Swenson; H D Ladley; W B Johnson; C G Anselone
Journal:  Am J Physiol       Date:  1985-09

9.  Variable effect of nifedipine on myocardial blood flow at three grades of coronary occlusion in the dog.

Authors:  W S Weintraub; S Hattori; J Agarwal; M M Bodenheimer; V S Banka; R H Helfant
Journal:  Circ Res       Date:  1981-06       Impact factor: 17.367

10.  Nifedipine prevents sympathetic vasoconstriction distal to severe coronary stenoses.

Authors:  G Heusch; A Deussen
Journal:  J Cardiovasc Pharmacol       Date:  1984 May-Jun       Impact factor: 3.105

View more
  6 in total

1.  Temporal and spatial changes in collateral formation and function during chronic myocardial ischemia.

Authors:  Michael P Robich; Robert M Osipov; Louis M Chu; Jun Feng; Thomas A Burgess; Shizu Oyamada; Richard T Clements; Roger J Laham; Frank W Sellke
Journal:  J Am Coll Surg       Date:  2010-08-21       Impact factor: 6.113

2.  Inotropic reserve and histological appearance of hibernating myocardium in conscious pigs with ameroid-induced coronary stenosis.

Authors:  Y T Shen; R K Kudej; S P Bishop; S F Vatner
Journal:  Basic Res Cardiol       Date:  1996 Nov-Dec       Impact factor: 17.165

3.  Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.

Authors:  K Harada; W Grossman; M Friedman; E R Edelman; P V Prasad; C S Keighley; W J Manning; F W Sellke; M Simons
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

4.  A minimally invasive method for induction of myocardial infarction in an animal model using tungsten spirals.

Authors:  Daniel Peukert; Michael Laule; Nicola Kaufels; Jörg Schnorr; Matthias Taupitz; Bernd Hamm; Marc Dewey
Journal:  Int J Cardiovasc Imaging       Date:  2009-02-25       Impact factor: 2.357

5.  Feasibility of subendocardial and subepicardial myocardial perfusion measurements in healthy normals with (15)O-labeled water and positron emission tomography.

Authors:  Ilse A Vermeltfoort; Pieter G Raijmakers; Mark Lubberink; Tjeerd Germans; Albert C van Rossum; Adriaan A Lammertsma; Paul Knaapen
Journal:  J Nucl Cardiol       Date:  2011-04-26       Impact factor: 5.952

Review 6.  Pathophysiology of coronary collaterals.

Authors:  Michael Stoller; Christian Seiler
Journal:  Curr Cardiol Rev       Date:  2014-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.